Howard L Kaufman

17PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 20, 2026
Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation.

|May 13, 2026
Local immunotherapy for the treatment of cancer: scientific advances and clinical potential.

|Jan 14, 2026
Targeting Tumor-Draining Lymph Nodes to Improve the Therapeutic Potential of Oncolytic Viruses.

Howard L Kaufman

|Sep 16, 2025
Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors.

Myla Hudson, Robert H Newman, Checo J Rorie

|Mar 13, 2025
A Pharmacokinetic and Pharmacodynamic Model of an IL-12 Anchored-Drug Conjugate for the Treatment of Solid Tumors.

Hitesh B Mistry, David Hodson, Sailaja Battula

|Feb 26, 2025
Using oncolytic viruses to induce hyperacute rejection against cancer.

Howard L Kaufman, Ann W Silk

Pageof 3

Frequent Collaborators

5 joint publications

Samuel D Rabkin

4 joint publications

Praveen K Bommareddy

3 joint publications

Dipongkor Saha

2 joint publications

Andrew Zloza